Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXeris Biopharma Regulatory News (0A8E)

Share Price Information for Xeris Biopharma (0A8E)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.080876
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2.080876
0A8E Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Xeris Pharmaceuticals, Inc 8.3 amend

15 Jun 2021 17:55

RNS Number : 0093C
J.P. Morgan Securities LLC
15 June 2021
 

Ap19

 

 

 

AMENDMENT

FORM 8.3

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

Name of person dealing (Note 1)

J.P. Morgan Securities LLC

Company dealt in

Xeris Pharmaceuticals, Inc.

Class of relevant security to which the dealings being disclosed relate (Note 2)

$0.001 common stock

Date of dealing

09 June 2021

 

2. INTERESTS AND SHORT POSITIONS

 

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

4,250,867 6.40

 

764,425 1.15

 

(2) Derivatives (other than options)

590,251 0.89

 

 

(3) Options and agreements to purchase/sell

 

 

Total

4,841,118 7.29

 

764,425 1.15

 

       

 

 

Ap20

 

 

1. DEALINGS (Note 4)

 

(a) Purchases and sales

 

 

Purchase/sale

 

Number of relevant securities

 

Price per unit (USD)

 

(Note 5)

Purchase (New Borrow)

 

Purchase (Loan Return)

 

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

Purchases

 

Sales

Sales

Sales

Sales

165,300

 

52,400

 

2

 1

 3

 8

 3

 1

 51

 23

 1

 4

 5

 

 51

 1,320

 100

 32

N/A

 

N/A

 

4.1000 USD

4.0900 USD

4.0733 USD

4.0675 USD

4.0633 USD

4.0600 USD

4.0598 USD

4.0583 USD

4.0500 USD

4.0275 USD

4.0240 USD

4.0598 USD

4.0100 USD

4.0025 USD

4.0000 USD

 

 

 

 

 

 

(b) Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(USD) (Note 5)

Equity Swap

Decrease Long

51

4.0598 USD

 

 

(c) Options transactions in respect of existing relevant securities

 

 

(i) Writing, selling, purchasing or varying

 

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

 

 

(ii) Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

 

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

 

Ap21

 

2. OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

 

 

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative

 referred to on this form is referenced. If none, this should be stated.

 

None

 

 

 

 

 

 

 

 

Is a Supplemental Form 8 attached? (Note 9)  NO

 

Date of disclosure

 15 June 2021

Contact name

Alwyn Basch

Telephone number

0207 742 7407

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISESFDFMIEFSEIM
Date   Source Headline
7th Oct 20213:09 pmRNSXeris Pharmaceuticals, Inc 8.3
6th Oct 20212:43 pmRNSXeris Pharmaceuticals, Inc 8.3
6th Oct 20212:42 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
5th Oct 20215:06 pmRNSXeris Pharmaceuticals, Inc 8.3 Amend
5th Oct 20213:15 pmRNSXeris Pharmaceuticals, Inc 8.3
4th Oct 20211:04 pmRNSXeris Pharmaceuticals, Inc 8.3
1st Oct 20213:05 pmRNSXeris Pharmaceuticals, Inc 8.3
1st Oct 202110:14 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
30th Sep 20215:07 pmRNSXeris Pharmaceuticals, Inc 8.3
30th Sep 20212:58 pmRNSXeris Pharmaceuticals, Inc 8.3
30th Sep 202110:22 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
29th Sep 20212:36 pmRNSXeris Pharmaceuticals, Inc 8.3
28th Sep 20212:22 pmRNSXeris Pharmaceuticals, Inc 8.3
28th Sep 20212:21 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
28th Sep 20212:19 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
27th Sep 202112:27 pmRNSXeris Pharmaceuticals, Inc 8.3
24th Sep 20214:35 pmRNSXeris Pharmaceuticals, Inc 8.3
24th Sep 20211:05 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
23rd Sep 20212:35 pmRNSXeris Pharmaceuticals, Inc 8.3
23rd Sep 20212:18 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
22nd Sep 20213:00 pmRNSXeris Pharmaceuticals, Inc 8.3
22nd Sep 20212:12 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
22nd Sep 202112:18 pmRNSForm 8.3 - XERIS PHARMACEUTICALS INC
21st Sep 20213:03 pmRNSXeris Pharmaceuticals, Inc 8.3
21st Sep 20212:17 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
21st Sep 20211:40 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
20th Sep 20211:53 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc
20th Sep 202112:29 pmRNSXeris Pharmaceuticals, Inc 8.3
20th Sep 202112:14 pmGNWInvesco ltd: Form 8.3 - Xeris Pharmaceutical Inc.
17th Sep 20213:20 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc.
17th Sep 20212:51 pmRNSXeris Pharmaceuticals, Inc 8.3
17th Sep 20212:05 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc
17th Sep 20211:13 pmEQSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc.
16th Sep 20213:20 pmRNSForm 8.3 - Xeris Pharmaceuticals, Inc.
16th Sep 20212:46 pmRNSXeris Pharmaceuticals, Inc 8.3
16th Sep 20211:58 pmGNWInvesco Ltd: Form 8.3 - Xeris Pharmaceutical Inc
16th Sep 202110:52 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
15th Sep 20211:58 pmRNSXeris Pharmaceuticals, Inc 8.3
15th Sep 202111:15 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC
15th Sep 202111:14 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
14th Sep 20212:24 pmRNSXeris Pharmaceuticals, Inc 8.3
14th Sep 20211:56 pmRNSMan Group PLC : Form 8.3 - Strongbridge biopharma plc
14th Sep 20211:03 pmRNSForm 8.3 - The Vanguard Group, Inc.: Xeris Pharmaceuticals, Inc.
13th Sep 202112:22 pmRNSXeris Pharmaceuticals, Inc 8.3
13th Sep 202112:15 pmGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
10th Sep 20212:42 pmRNSXeris Pharmaceuticals, Inc 8.3
10th Sep 20217:21 amGNWMan Group PLC : Form 8.3 - Strongbridge Biopharma plc
9th Sep 20211:49 pmRNSXeris Pharmaceuticals, Inc 8.3
9th Sep 202111:15 amRNSForm 8.3 - Xeris Pharmaceuticals, Inc
9th Sep 202111:13 amRNSForm 8.3 - XERIS PHARMACEUTICALS INC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.